BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-73@pharmaconomics
DTSTAMP:20260707T014748Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:SNY Phase 3 — PCV21
DESCRIPTION:Phase 3 trial results for PCV21 in Pneumococcal Infections are due Dec 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT06838000\n\nTrack it: https://pharmaconomics.com/e/73
URL:https://pharmaconomics.com/e/73
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:SNY catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR